Propanc Biopharma Inc (PPCB)

[Diggnun21]

IMO, Propanc is the opposite of other OTC market scam companies. Just take a look at the credentials, expertise, and experience of their Board of Directors and Scientific Board. This company has value in the long term and they know how to take a drug to market; for goodness sake, John Smythe (on the Scientific Board) is Chairs of the Expert Advisory Group for Oncology & Haematology for the Commission on Human Medicines and serves on the Expert Oncology Advisory Group to the European Drug Licensing Board. If he has confidence that PRP will get FDA approved, I have no reason to believe he would ever be wrong. Remember, FDA approval require safety and efficacy and so far, all Propanc's pilot studies (ion animals and humans) have proven both. Also, I do not foresee them delivering us a R/S. They value their shareholders commitment to the company and once they get FDA approval for PRP as IND, they will have financiers waiting in line to put up the cash. They don't need to R/S and ruin their relationship with shareholders. And if they were gonna do a r/s there have been many opportunities for them to do so, much more ideal than the current PPS. I am going to email them and let them know investors concerns about R/S and see if I get a response. If this was one of the thousands of other companies on the OTC, I would tend to agree with you. But here, I just can't. I see Propanc moving to Nasdaq by years end, with a PPS in the $1-3 range and a revolutionary cancer drug line that can be used a primary treatment or in adjunct with chemotherapy.